General Information of Drug (ID: DMDWGTG)

Drug Name
HI-con1
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 2 [1]
Cross-matching ID
TTD ID
D0W8YY

References

1 ClinicalTrials.gov (NCT02358889) Study Evaluating Intravitreal hI-con1 in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration. U.S. National Institutes of Health.